Alexander Ilic

Xantos AG is a functional biology and drug discovery company developing biopharmaceuticals in the areas of cancer and metabolic diseases. Its business model is to develop drug discovery pipelines based on the validated targets and leads generated by its proprietary through target identification and validation system and to form indication specific joint research and development collaborations with pharmaceutical and biotechnology companies. It also offers customers its proprietary technology and cDNA/siRNA screening tools for research service deals. The company is headquartered in Munich, Germany.

Hälg & Co. AG provides building technology services and solutions in the areas of heating, ventilation, air conditioning, refrigeration, and sanitation. The company was founded by Ferdinand Hälg in 1922 and is headquartered in St. Gallen, Switzerland.

Haakon Ltd. is based in Basel, Switzerland. The Swiss company operates internationally with a focus on property casualty, liability, marine, accident, health & life, energy, engineering, motor, agriculture, and aviation insurance. Haakon provides clients with technical expertise in designing and placing reinsurance solutions. The majority shareholder of Haakon Ltd. is the Bâloise Insurance Group. Part of Howden Group Holdings Ltd., Haakon is a specialist reinsurance broker founded in 1980. The CEO of the company is Thomas Meier. Haakon was acquired by Howden Schweiz AG from Bâloise Holding AG on December 04, 2023.

Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.

Lightbird Ventures AG (Lightbird) is a venture capital firm founded in 2021. The firm is headquartered in Bern, Switzerland.

Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006.

JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.

Fortimo Group AG operates as a holding company, which engages in the acquisition, brokerage, development, and sale of residential real estate. It offers properties for sale such as condominiums, single-family houses, commercial buildings, and building land. The firm also subleases properties such as apartments, single-family houses, and commercial buildings. The company was founded by Philipp Bienz and Remo Bienz in 2000 and is headquartered in St. Gallen, Switzerland.

Tube Pharmaceuticals GmbH develops a new class of anti cancer drugs. Its products include Tubulysins and their synthetic analogs and next generation Epothilones. The company assets are natural product classes and their synthetic analogues comprising a product platform with multiple partnering and development opportunities. It focuses on synthetic substances for the cancer therapy, derived from natural substances. The company was founded in 2011 and is headquartered in Vienna, Austria.

Censhare AG develops online platform which pools all marketing and communications content within one information-centric system. The company is headquartered in Munich, Germany.

Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA.

EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.